COVID-19 Associated Pulmonary Aspergillosis: A Case Series.
Acta Med Indones
; 54(2): 292-298, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1929565
ABSTRACT
Coronavirus disease 2019 (COVID-19) has been a worldwide pandemic with several problems, one of which is the lack of definitive treatment. COVID-19-associated pulmonary aspergillosis (CAPA), the presence of invasive pulmonary aspergillosis (IPA) in COVID-19 patients, is one of the concerning secondary infections associated with higher mortality and worse clinical outcomes. Diagnosing CAPA may be challenging due to the possible absence of classic host factors and clinical symptoms or obscured radiological findings. We described two CAPA cases, which were suspected due to persistent respiratory failure despite standard treatment of COVID-19 with additional therapies and antimicrobial agents for secondary infections, eventually diagnosed with serum galactomannan testing. Clinical conditions of both patients improved significantly after the administration of voriconazole. This case series emphasizes the importance of being aware of clinical suspicions indicating CAPA followed by galactomannan testing as a relatively fast, noninvasive test for its diagnosis, which leads to appropriate antifungal treatment.
Palabras clave
Buscar en Google
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Aspergilosis Pulmonar Invasiva
/
COVID-19
Tipo de estudio:
Reporte de caso
/
Estudios diagnósticos
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
Acta Med Indones
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Indonesia
Similares
MEDLINE
...
LILACS
LIS